Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Phase Transfer Catalysis (PTC). These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN102030717B reveals an aqueous phase transfer catalysis route for 1,3,5-tripropargyl-1,3,5-triazine-2,4,6-trione, enabling cost reduction in polymer additive manufacturing.
Patent CN1271027C details a solvent-free phase transfer catalysis method for dihalogenated aromatic ethers, offering high purity (>95%) and yield (>90%) for agrochemical intermediates.
Patent CN112538058B introduces a streamlined synthesis of oxazole-containing sulfone compounds via phase-transfer-catalyzed cyclization. This method eliminates multi-step sequences and expensive metal catalysts, enabling cost reduction in pharmaceutical intermediate manufacturing while ensuring high-purity output and scalable production for global supply chains.
Patent CN101857613A reveals a novel PTC synthesis for anti-influenza rupestonic acid esters, offering cost reduction in API manufacturing and scalable production.
Patent CN101659642B details a novel phase-transfer catalytic route for sulfonylureas, offering safer agrochemical manufacturing and significant cost reduction.
Patent CN100540519C reveals a safer PTC-catalyzed route for 3,4-dimethoxyphenylacetaldehyde. Achieve high purity and cost reduction in API manufacturing with scalable methods.
Patent CN1910180A details a safer PTC-catalyzed route for tropane intermediates, offering high purity and scalable manufacturing for CNS drug supply chains.
Novel phase-transfer catalysis process for anti-inflammatory intermediates. Reduces dialkylation impurities and simplifies purification for cost-effective API manufacturing.
Patent CN101023077B details a high-yield phase transfer process for R-sertaconazole nitrate, offering significant cost reduction and supply chain reliability for API manufacturers.
Patent CN101857547A reveals a mild PTC method for 2-nitro-1-aryl alcohol synthesis, offering high purity, scalable production, and significant cost reduction in API manufacturing.
Patent CN1276913C details a high-yield aqueous method for venlafaxine intermediates, offering significant cost reduction and supply chain reliability for pharmaceutical manufacturers.